Clinical Trial Update: The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating febuxostat's effect on coronary artery endothelial function in chronic stable angina. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Angina

Drugs mentioned

• Febuxostat (Uloric) (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-04-13